HEDS Home Page

Welcome to the Health Economics and Decision Science Section of ScHARR

The Section

The purpose of HEDS is to promote excellence in health care resource allocation decisions. HEDS makes major contributions in areas that include the valuation of health, the analysis of health policy, welfare and equity, technology appraisal,evidence synthesis, econometrics and information sciences.

We also lead several national research collaborations, supervise PhD students, contribute to Masters programmes, deliver external training courses and provide input to national committees. Find out more about our activities in the most recent issue of our newsletter.

Latest publications

A. Scope, L. Uttley, and A. Sutton. A qualitative systematic review of service user and service provider perspectives on the acceptability, relative benefits, and potential harms of art therapy for people with non-psychotic mental health disorders. Psychol Psychother, Jun. 2016.

A. J. Hatswell, J. Porter, D. Lee, N. Hertel, and N. R. Latimer. The Cost of Costing Treatments Incorrectly: Errors in the Application of Drug Prices in Economic Evaluation Due to Failing to Account for the Distribution of Patient Weight. Value Heal., Jun. 2016.

C. J. McDermott, et. al. DiPALS: Diaphragm Pacing in patients with Amyotrophic Lateral Sclerosis - a randomised controlled trial. Heal. Technol Assess, vol. 20, no. 45, pp. 1–186, Jun. 2016.

Consultancy, Innovation & Knowledge Transfer

HEDS delivers a vibrant portfolio of consultancy-funded research to the pharmaceutical and medical devices sector and the NHS. It utilises our broad range of skills and is complemented by tailored training courses covering a full range of research methods, as well as policy issues such as pricing and reimbursement. If you want to discuss any opportunities, please contact the ScHARR IKT team.

Latest project news

INTEGRATE-HTA is an innovative, EU funded project that ended in December 2015. Using palliative care as a case study, this project aimed to develop concepts and methods that enable a patient-centred, comprehensive assessment of complex health technologies. Members of HEDS have been involved in authoring the methodological reports in a series of eight reports produced by the INTREGRATE-HTA collaborative project. All reports are available here.

Developing a method to assist investment decisions in specialised commissioning
As part of the development process, NHS England commissioned HEDS to undertake a review of effectiveness and cost-effectiveness measurement in MCDA, and recommend methods to use in their new methodology. Available on the consultation website.

Section Director

Professor Simon Dixon

Deputy Section Director

Dr Eva Kaltenthaler

HEDS blog

The best way to keep up with our work and our impact on policy is to read the HEDS Blog. With over 70,000 hits from over 110 different countries recent blog posts also feature on Twitter: